CEBPB and breast cancer: In conclusion, our findings suggest that the expression/activity of C/EBP-β and PLK1, factors already involved in BC aggressiveness as well as targets of different molecules dismissed by a dysfunctional adipose tissue, are exacerbated by adipocyte-derived CM.